Kangji Medical Holdings Limited (HKG: 9997)

Market Cap	6.69B
Revenue (ttm)	1.05B
Net Income (ttm)	574.22M
Shares Out	1.21B
EPS (ttm)	0.49
PE Ratio	11.28
Forward PE	9.77
Dividend	0.45 (8.15%)
Ex-Dividend Date	May 29, 2024

Volume	975,000
Open	5.51
Previous Close	5.53
Day's Range	5.18 - 5.51
52-Week Range	5.18 - 8.20
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2024

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, such as trocars, uterine manipulator, specimen retrieval bag, incision dilator, powered linear stapler and reloads, endoscopic stapler, suction and irrigation sets, closure forceps, and visual guidance D and C suction probe, as well as polymer ligation clips. It provides disposable elec...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,003
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9997

Financial Performance

In 2023, Kangji Medical Holdings's revenue was 926.02 million, an increase of 17.76% compared to the previous year's 786.37 million. Earnings were 504.02 million, an increase of 5.28%.

Financial numbers in CNY